Currently, doctors do not treat breast cancer patients with obesity-driven diabetes any differently than those without ...

The "Innovation Insights: Engineered Exosomes" report has been added to ResearchAndMarkets.com's offering. In the Engineered Exosome drug deals, there have been 77 deals totaling US$5.1 billion, with ...

Extracellular vesicles play a vital role in cell biology, modulating communication and signaling, with potential applications in diagnostics and therapeutics.

The world of skincare is always evolving, which means trying to keep up with all the latest buzzwords. Here, we’ve ...

A recent study published in the journal Engineering delves into the application of tissue engineering in spinal cord injury (SCI) repair, presenting a comprehensive review of the latest research and ...

Lallemand Health Solutions is proud to announce the latest findings from a comprehensive study on Cerebiome, a pioneering ...

Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.

RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, today announced the ...

Joana Correia, Co-Founder and CEO, Exogenus Therapeutics, commented, “This collaboration with Lonza will be essential to ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases.